Cargando…

Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Wang, Liang, Shi, Caiyan, Yu, Jie, Xu, Yilin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730665/ https://www.ncbi.nlm.nih.gov/pubmed/36476228 http://dx.doi.org/10.1186/s12935-022-02802-9

Ejemplares similares

FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2018)

Correction to: Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
por: Zhang, Xue, et al.
Publicado: (2021)

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021)

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2019)

FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression
por: Varghese, Vidhya, et al.
Publicado: (2019)

Correction: ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A
por: Cui, Meng, et al.
Publicado: (2023)

CircFOXM1 acts as a ceRNA to upregulate SMAD2 and promote the progression of nasopharyngeal carcinoma
por: Pei, Shuai, et al.
Publicado: (2022)

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
por: Zhang, Heyun, et al.
Publicado: (2021)

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
por: Hu, Guohui, et al.
Publicado: (2019)

Correction to “Downregulation of FoxM1 inhibits the viability and invasion of gallbladder carcinoma cells, partially dependent on the induction of cellular senescence”
por: Tao, Jie, et al.
Publicado: (2021)

Author Correction: Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2019)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Li, Shuai, et al.
Publicado: (2021)

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2018)

Correction: Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect
por: Zhang, Qiang, et al.
Publicado: (2022)

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
por: Cao, Man-Qing, et al.
Publicado: (2018)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence
por: Zhang, Sha, et al.
Publicado: (2020)

Correction to: ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
por: Liu, Danfei, et al.
Publicado: (2021)

Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2022)

Correction: TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1
por: Zheng, Shuier, et al.
Publicado: (2022)

FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
por: Yu, Chun-Peng, et al.
Publicado: (2017)

Correction to: Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)
por: Lu, Yi-fang, et al.
Publicado: (2020)

Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
por: Qu, Kai, et al.
Publicado: (2022)

TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background
por: Guijarro, Maria V., et al.
Publicado: (2023)

circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1
por: Cheng, Zhuoan, et al.
Publicado: (2019)

Correction to: Three novel circRNAs upregulated in tissue and plasma from hepatocellular carcinoma patients and their regulatory network
por: Wang, Lianghai, et al.
Publicado: (2021)

USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1
por: Li, Xiaofeng, et al.
Publicado: (2023)

Correction: E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma
por: Xu, Jing, et al.
Publicado: (2022)

Test Your Memory (TYM) and Test Your Memory for Mild Cognitive Impairment (TYM-MCI): A Review and Update Including Results of Using the TYM Test in a General Neurology Clinic and Using a Telephone Version of the TYM Test
por: Brown, Jeremy M., et al.
Publicado: (2019)

FOXM1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Upregulating SNAIL
por: Wei, Ping, et al.
Publicado: (2015)

The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis
por: Wang, Yongjia, et al.
Publicado: (2022)

Correction to: PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
por: Zhou, Wuhua, et al.
Publicado: (2018)

Correction to: PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
por: Zhou, Wuhua, et al.
Publicado: (2019)

Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
por: Zhou, Lisha, et al.
Publicado: (2023)

Correction: Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma
por: Chang, Te-Sheng, et al.
Publicado: (2017)

Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

Correction: Upregulation of microRNA-125b by G-CSF promotes metastasis in colorectal cancer
por: Zhang, Xinghua, et al.
Publicado: (2020)

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022)

Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
por: Zhang, Xue, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gg4boqh39oej3p9hvf4jip1l2g